Cancer Statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 12K |
Cancer nanomedicine: progress, challenges and opportunities | Nature Reviews Cancer | 2017 | 3K |
Colorectal cancer statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 2.6K |
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | JAMA Oncology | 2017 | 2.4K |
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses | Neoplasia | 2017 | 2.2K |
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells | Cancer Research | 2017 | 1.9K |
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging | Ca-A Cancer Journal for Clinicians | 2017 | 1.8K |
Tumour-associated macrophages as treatment targets in oncology | Nature Reviews Clinical Oncology | 2017 | 1.6K |
Computational Radiomics System to Decode the Radiographic Phenotype | Cancer Research | 2017 | 1.6K |
Japanese gastric cancer treatment guidelines 2014 (ver. 4) | Gastric Cancer | 2017 | 1.6K |
Radiomics: the bridge between medical imaging and personalized medicine | Nature Reviews Clinical Oncology | 2017 | 1.6K |
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States | JAMA Oncology | 2017 | 1.4K |
Long Noncoding RNA and Cancer: A New Paradigm | Cancer Research | 2017 | 1.3K |
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study | Lancet Oncology, The | 2017 | 1.3K |
Wnt signaling in cancer | Oncogene | 2017 | 1.2K |
Liquid biopsies come of age: towards implementation of circulating tumour DNA | Nature Reviews Cancer | 2017 | 1.2K |
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers | Molecular Cancer Therapeutics | 2017 | 1.2K |
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | Nature Reviews Clinical Oncology | 2017 | 1.2K |
Targeting autophagy in cancer | Nature Reviews Cancer | 2017 | 1.2K |
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2017 | 1.1K |
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 1K |
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics | Lancet Oncology, The | 2017 | 1K |
Influence of diet on the gut microbiome and implications for human health | Journal of Translational Medicine | 2017 | 983 |
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial | Lancet Oncology, The | 2017 | 981 |
Integrating liquid biopsies into the management of cancer | Nature Reviews Clinical Oncology | 2017 | 970 |